Dr. Alan Feiner, MD

• Hematology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Colorado Health Sciences Center

  Fellowship Hospital

• University Of Colorado School Of Medicine

  Fellowship Hospital

• Northwestern University Feinberg School Of Medicine

  Residency Hospital

• Northwestern University Feinberg School Of Medicine

  Internship Hospital

• University Of Colorado School Of Medicine

  Medical School, 1973

• American Society of Hematology, Member

• Rose Medical Center Tumor Board, Chair

• American Society of Clinical Oncology, Member

• American College of Physicians, Fellow

• Feiner AS, Myers AM, Moore GE: Leukemic reticuloendotheliosis, loss of platelets defect after splenectomy. JAMA 240: 238-240, 1978.

• Wettlaufer JN, Feiner AS, Robinson WA: Vincristine, cis-platinum, and Bleomycin with Surgery in treatment of non-seminomatous testis Tumors. ASCO Abstracts C-552, 1981.

• Feiner, AS, Mahmood T: Hodgkin’s disease 1972-1977. Rocky Mountain Medical Journal 76: 17-20, January-February 1979.

• Wettlaufer JN, Feiner AS, Robinson WA: Vincristine, cis-platinum, and Bleomycin with Surgery in the management of advanced Metastatic non-seminomatous testis tumors. Cancer 53: 203-209, 1984.

• Feiner AS: When “patient autonomy” is not the Answer. Frontlines 1:7-8, 1984.

• Feiner AS, Hematologic Disorders in: Abrams R, Wexler P, eds. Medical Care of the Pregnant Patient: Concepts and Management. Boston: Little, Brown, 1983.

• Feiner AS, Mahmood T, Walner SF: Prognostic Importance of pruritus in Hodgkin’s disease. JAMA 240: 2738-2749, 1978.

• Feiner AS, Loar C: Intraductal carcinoma of the breast at Rose Medical Center – patient care study. In 1986 Annual Report and Breast Monograph, Rose Medical Center Tumor Registry and Cancer Committee, Pp 11-13.

• Feiner AS: Chemotherapy in testicular cancer: the adventure continues. 1991 Annual Report, Rose Tumor Registry and Cancer Committee, pp 19-24.

• Feiner AS, Myers AM, Moore GE: Leukemic reticuloendotheliosis, loss of platelets defect aftersplenectomy. JAMA 240: 238-240, 1978.

• Feiner AS: Combined modality therapy of Hodgkin’s and non-Hodgkin’s lymphoma –Is more better? 1990 Annual Report, Rose Tumor Registry and Cancer Committee, pp 41-43.

• Feiner AS, Mahmood T: Hypothetical case of Iron deficiency. Postgraduate Medicine 66: 119-126, December 1979.

• Feiner AS, Loar C: Hodgkin’s Disease at Rose Medical Center and subsequent risk of breast cancer, 1993 Annual Report, Rose Tumor Registry and Cancer Committee, pp 13-14.

• Feiner AS, Novak SL: Task forces in a community hospital oncology program. Field Liaison Newsletter, American College of Surgeons, August 1982.

• Feiner AS, Loar C: Recent trends in the treatmentOf breast cancer at Rose Medical Center. 1985 Annual Report Rose Tumor Registry and Cancer Committee, pp 10-11.

• Postgraduate Medicine, July 1981, p. 21, Review of Practical Oncology by Sarna et al.

• Eiseman B, Feiner AS: Cost effective follow-up of the cancer patient. Postgraduate Medicine 1988; 83(1):119-126.

• Wettlaufer JN, Feiner AS: Vincristine, cis-platinum And Cytoxan in the management of advanced Seminoma. American Urological Association Annual meeting, 1987, Abstract 429.